Chinopoulos Christos: Difference between revisions

From Bioblast
No edit summary
No edit summary
 
(28 intermediate revisions by 8 users not shown)
Line 1: Line 1:
{{EAGLE
{{EAGLE
|COST= Participant
|COST= Member
|COST WG1 = WG1
|COST Mentor= Mentor
}}
}}
: [[Management_Committee_MitoEAGLE#MC_Members|MC Member]] - [[Management Committee MitoEAGLE]]
{{Person
{{Person
|lastname=Chinopoulos
|lastname=Chinopoulos
Line 8: Line 11:
|institution=[[File:Christos Chinopoulos.jpg|right|150px|Christos Chinopoulos]]
|institution=[[File:Christos Chinopoulos.jpg|right|150px|Christos Chinopoulos]]


Department of Medical Biochemistry
Department of Medical Biochemistry,


Semmelweis University
Semmelweis University, HU
|address=Tuzolto st. 37-47
|address=Tuzolto st. 37-47
|area code=1094
|area code=1094
|city=Budapest
|city=Budapest
|country=Hungary
|country=Hungary
|mailaddress=chinopoulos.christos@med.semmelweis-univ.hu
|weblink=[http://www.oxphos.org/index.php?option=content&task=view&id=55 Christos Chinopoulos]
|weblink=[http://www.oxphos.org/index.php?option=content&task=view&id=55 Christos Chinopoulos]
}}
}}
__TOC__
== Bioenergetics Communications ==
::::* Christos Chinopoulos is an Executive Editor of the journal '''[[Bioenergetics Communications]]'''
:::::'''Keywords:''' mitochondria, oncometabolism, tumor metabolism, substrate-level phosphorylation
{{NextGen-O2k H2020-support}}
== NextGen-O2k ==
::::* Prof. Christos Chinopoulos is Key Opinion Leader (KOL) in the [[NextGen-O2k]] project.
== MitoEAGLE Short-Term Scientific Mission ==
****: [[Short-Term Scientific Missions MitoEAGLE#STSM_Grant_Period_2 |STSM Grant Period 2]]
::: '''Work Plan summary'''
:::: In our laboratory we examine the contribution of mitochondrial substrate-level phosphorylation (mSLP) to ATP output and ANT directionality during true anoxia or inhibition of the electron transport chain (ETC) in isolated mitochondria or permeabilized cells. True anoxia is ensured by monitoring oxygen concentration in sealed Oroboros chambers when mitochondria respire on various substrates in the abundance of ADP. On the other hand, chemical anoxia is induced by targeted inhibition of ETC components. Under such conditions mSLP is addressed by protocols relying on membrane potential measurements using safranine O, also monitored by the O2k-Fluo LED2-Module, as described elsewhere (FASEB J. 2010, 24:2405). However, it has come to our attention that targeted inhibition of complex I perturbs mSLP even in the presence of true anoxia. Parallel to these measurements, metabolomic analysis of citricacid cycle metabolites obtained from fractions of such experiments hint on a privileged dependence of complex I activity to KGDHC. Currently, we are attempting to address this further by measuring NADH in standard fluorimetric cuvettes using home-made 3D-printed plugs in order to induce and maintain anoxia where we can also measure membrane potential by safranine O among other parameters. However, we are only partially successful, and we need to be able to measure oxygen, NADH and safranine O fluorescence in the same samples (albeit in different chambers), simultaneously. The O2k-NextGen is designed by Oroboros for achieving exactly that. The plan is to isolate mouse liver mitochondria, subject them to ADP and substrates in sealed Oroboros chambers, attain anoxia, add the ETC inhibitors and collect fractions at various time points to be evaluated by untargeted metabolomic analysis. Anoxia, NADH levels and membrane potential will be measured throughout these experiments and complement the results of the metabolomic analysis.
== Participated at ==
::::* [[MiPNet 26.16 NextGen-O2k Summit 2021 Virtual|NextGen-O2k Summit 2021 Virtual]]
::::* [[IOC141|IOC141 Schroecken AT]]
::::* [[MitoEAGLE_Innsbruck_2018-11-19| MitoEAGLE 2018 Innsbruck AT]]
::::* [[MiP2018/MitoEAGLE Jurmala LV|MitoEAGLE 2018 Jurmala LV]]
::::* [[IOC127|IOC127 Szeged HU]]
::::* [[MitoFit Workshop ATP 2017 Innsbruck AT]]
::::* [[IOC116|IOC116 Innsbruck AT]]
::::* [[Bioblast 2012 | Bioblast 2012 Innsbruck AT]]
::::* [[IOC66 | IOC66 Innsbruck AT]]
::::* [[IOC127|IOC127 Szeged HU]]
== Visiting scientist in the Oroboros O2k-Laboratory ==
:::: [[Image:O2k-Network.png|left|40px|link=O2k-Network|O2k-Network]]
[[Chinopoulos Christos| Christos Chinopoulos ]]: Visiting scientist at the [[Oroboros Laboratories: visiting scientists |Oroboros O2k-Laboratory]]
::::::* December 14 to December 22 2017
{{Labelingperson
{{Labelingperson
|field of research=Basic
|field of research=Basic
|topics=Mitochondrial mechanisms of neurodegeneration, Permeability transition pore
|topics=Mitochondrial mechanisms of neurodegeneration, Permeability transition pore
}}
}}
== Participated at ==
* [[Bioblast 2012 | Bioblast 2012 Innsbruck AT]
* [[IOC66 | IOC66 Innsbruck AT]]

Latest revision as of 11:16, 3 May 2024


MiPsociety
News and Events        
BEC 2020.1 Mitochondrial physiology
       
MitoEAGLE
        Working Groups         Short-Term Scientific Missions         Management Committee         Members        
MitoGlobal
   


EU-logo.jpg

COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping


Chinopoulos Christos


MitoPedia topics: MitoPedia topic::EAGLE 

COST: Has COST::Member COST WG1: Has COST WG1::WG1


COST Mentor: Has COST Mentor::Mentor

MC Member - Management Committee MitoEAGLE
Name Has lastname::Chinopoulos Has firstname::Christos, Has title::MD, PhD, Associate Professor
Institution [[Has institution::
Christos Chinopoulos

Department of Medical Biochemistry,

Semmelweis University, HU]]

Address Has address::Tuzolto st. 37-47, Has area code::1094
City In city::Budapest
State/Province In state::
Country In country::Hungary
Email Has mailaddress::[email protected]
Weblink [[Weblink::Christos Chinopoulos]]
O2k-Network Lab {{#ask:has member::Chinopoulos Christos}}

Bioenergetics Communications

Keywords: mitochondria, oncometabolism, tumor metabolism, substrate-level phosphorylation
Template NextGen-O2k.jpg

NextGen-O2k

  • Prof. Christos Chinopoulos is Key Opinion Leader (KOL) in the NextGen-O2k project.

MitoEAGLE Short-Term Scientific Mission

Work Plan summary
In our laboratory we examine the contribution of mitochondrial substrate-level phosphorylation (mSLP) to ATP output and ANT directionality during true anoxia or inhibition of the electron transport chain (ETC) in isolated mitochondria or permeabilized cells. True anoxia is ensured by monitoring oxygen concentration in sealed Oroboros chambers when mitochondria respire on various substrates in the abundance of ADP. On the other hand, chemical anoxia is induced by targeted inhibition of ETC components. Under such conditions mSLP is addressed by protocols relying on membrane potential measurements using safranine O, also monitored by the O2k-Fluo LED2-Module, as described elsewhere (FASEB J. 2010, 24:2405). However, it has come to our attention that targeted inhibition of complex I perturbs mSLP even in the presence of true anoxia. Parallel to these measurements, metabolomic analysis of citricacid cycle metabolites obtained from fractions of such experiments hint on a privileged dependence of complex I activity to KGDHC. Currently, we are attempting to address this further by measuring NADH in standard fluorimetric cuvettes using home-made 3D-printed plugs in order to induce and maintain anoxia where we can also measure membrane potential by safranine O among other parameters. However, we are only partially successful, and we need to be able to measure oxygen, NADH and safranine O fluorescence in the same samples (albeit in different chambers), simultaneously. The O2k-NextGen is designed by Oroboros for achieving exactly that. The plan is to isolate mouse liver mitochondria, subject them to ADP and substrates in sealed Oroboros chambers, attain anoxia, add the ETC inhibitors and collect fractions at various time points to be evaluated by untargeted metabolomic analysis. Anoxia, NADH levels and membrane potential will be measured throughout these experiments and complement the results of the metabolomic analysis.


Participated at


Visiting scientist in the Oroboros O2k-Laboratory

O2k-Network

Christos Chinopoulos : Visiting scientist at the Oroboros O2k-Laboratory

  • December 14 to December 22 2017


Labels: Field of research: field of research::Basic  Topics: topics::Mitochondrial mechanisms of neurodegeneration, topics::Permeability transition pore 


Publications

{{#ask:was written by::Chinopoulos Christos|format=table|sort=was published in year|order=desc|default=Add references to your publications

| ?was published in year=Published | ?has title=Reference | limit=2000 }}

Abstracts

{{#ask:was written by::Chinopoulos Christos|format=table|sort=was submitted in year|order=desc|default=Add abstract

| ?was submitted in year=Published | ?has title=Reference | limit=2000 }}